Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
Motley Fool
Mon, 05/8/23 - 11:46 pm
JNJ
consumer health
spinoffs
Kenvue
Judge orders J&J, talc opponents to engage in settlement talks
Fierce Pharma
Fri, 05/5/23 - 10:15 am
JNJ
legal
bankruptcy
J&J sets top price for consumer health unit Kenvue’s IPO
Pharmaphorum
Thu, 05/4/23 - 09:57 am
JNJ
spinoff
Kenvue
IPOs
consumer health
J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies
BioSpace
Tue, 05/2/23 - 11:46 am
JNJ
Janssen
Cellular Biomedicine
CAR-T
diffuse large B-cell lymphoma
The FTC put pharma giants on notice for deceptive marketing claims. But does it actually have the authority?
Medical Marketing and Media
Thu, 04/27/23 - 10:44 pm
FTC
pharma marketing
deceptive marketing
JNJ
Pfizer
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
AbbVie
Amgen
Bristol Myers Squibb
Eli Lilly
Gilead Sceinces
JNJ
Merck
Pfizer
Regeneron
patents
activists
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
CNBC
Tue, 04/25/23 - 10:44 am
JNJ
consumer health
IPOs
Kenvue
spinoffs
J&J takes on Medtronic and Boston in pulsed field ablation
EP Vantage
Tue, 04/25/23 - 10:34 am
JNJ
Medtech
pulsed field ablation
Medtronic
Boston Scientific
atrial fibrillation
Varipulse
Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways
Benzinga
Tue, 04/25/23 - 10:28 am
Genmab
JNJ
Janssen
Darzalex
J&J claims first approval for PARP combo Akeega
Pharmaphorum
Mon, 04/24/23 - 10:22 am
JNJ
Janssen
Akeega
PARP inhibitors
metastatic castration-resistant prostate cancer
Europe
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Amgen
Regeneron Pharmaceuticals
Sanofi
Supreme Court
patents
Pfizer
Bayer
Roche
Genentech
AstraZeneca
JNJ
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
R&D
AbbVie
Amgen
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
GSK
JNJ
Merck
Merck KGaA
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
UCB
Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
M&A
R&D
AbbVie
AstraZeneca
Bristol Myers Squibb
Eli Lilly
GSK
JNJ
Merck
Novartis
Pfizer
Roche
Sanofi
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
CAR-T
Bristol Myers Squibb
JNJ
Legend Biotech
AACR
Multiple Myeloma
Carvykti
Abecma
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
Fierce Biotech
Tue, 04/18/23 - 10:13 am
JNJ
Janssen
earnings
restructuring
infectious disease
J&J opens the valve on $50M MS partnership with Pipeline
Fierce Biotech
Mon, 04/17/23 - 12:40 pm
JNJ
Pipeline Therapeutics
MS
multiple sclerosis
PIPE-307
Why Johnson & Johnson Paying $8.9 Billion to Settle Its Talc Lawsuits Would Be Good News
Motley Fool
Fri, 04/14/23 - 09:55 am
JNJ
legal
J&J opens its wallet with whopping $8.9B talc settlement offer
Fierce Pharma
Tue, 04/4/23 - 11:30 pm
JNJ
legal
After Johnson & Johnson loses again in bankruptcy case, it's game on for talc lawsuits
Fierce Pharma
Mon, 04/3/23 - 09:47 am
JNJ
bankruptcy
legal
Could This Move by Johnson & Johnson Equal Billions for Moderna?
Motley Fool
Sun, 04/2/23 - 04:19 pm
JNJ
Moderna Therapeutics
Pfizer
GSK
RSV
vaccines
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »